Show simple item record

dc.contributor.authorRahimpour, Y
dc.contributor.authorKouhsoltani, M
dc.contributor.authorHamishehkar, H
dc.date.accessioned2018-08-26T06:06:53Z
dc.date.available2018-08-26T06:06:53Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/42084
dc.description.abstractThe aerosolization efficiency of a powder is highly dependent on carrier characteristics, such as particle size distribution, shape and surface properties. The main objective in the inhalation field is to achieve a high and reproducible pulmonary deposition. This can be provided by successful carrier selection and careful process optimization for carrier modification. Lactose is the most common and frequently used carrier in dry powder inhaler (DPI) formulations. But lactose shows some limitations in formulation with certain drugs and peptides that prohibit its usage as a carrier in DPI formulations. Here, we criticality review the most important alternative carriers to lactose with merits, demerits and applications in DPI formulations.
dc.language.isoEnglish
dc.relation.ispartofDrug discovery today
dc.subjectAnimals
dc.subjectChemistry, Pharmaceutical
dc.subjectDrug Carriers
dc.subjectDrug Delivery Systems
dc.subjectDry Powder Inhalers
dc.subjectHumans
dc.subjectLung
dc.subjectMannitol
dc.subjectSorbitol
dc.titleAlternative carriers in dry powder inhaler formulations.
dc.typearticle
dc.citation.volume19
dc.citation.issue5
dc.citation.spage618
dc.citation.epage26
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.drudis.2013.11.013


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record